Tirzepatide, Semaglutide, Wegovy & Zepbound in Miami Beach Weight Loss with GLP-1s GLP-1 medications like Tirzepatide, Semaglutide, Wegovy, and Zepbound have transformed medically supervised weight loss by reducing appetite, improving metabolic function, and supporting meaningful, sustained weight reduction
Studies such as LEADER, SUSTAIN-6, REWIND, SELECT, and most recently the SOUL trial demonstrated that certain GLP-1 receptor agonists were associated with reductions in major adverse cardiovascular events, including heart attack, stroke, and cardiovascular death.[4][5][6][7] Much of the semaglutide cardiovascular evidence, in particular, has shaped how doctors now think about these medicines
While some might assume they are redundant, using both can address the bodys needs from two different angles
Potential Nutrient Deficiencies : Semaglutide can reduce appetite, which may lead to lower intake of essential nutrients like iron, vitamin B12, and folate
In the STEP clinical trials, patients on semaglutide 2.4 mg weekly lost an average of 14.9% body weight over 68 weeks
Retrieved from: NPR
